🇺🇸 FDA
Patent

US 10632251

Device, system and methods for the oral delivery of therapeutic compounds

granted A61KA61K38/13A61K38/21

Quick answer

US patent 10632251 (Device, system and methods for the oral delivery of therapeutic compounds) held by Rani Therapeutics, LLC expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rani Therapeutics, LLC
Grant date
Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/13, A61K38/21, A61K38/26, A61K38/27